查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088744

恒溫核酸增幅技術市場：全球市場預測（按產品類型、工作流程、技術、最終用戶和應用分類），2026-2032年

Isothermal Nucleic Acid Amplification Technology Market by Product Type, Workflow, Technology, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，恒溫核酸增幅技術市場規模將達到 137.7 億美元，複合年成長率為 13.09%。

主要市場統計數據
基準年 2025 58.1億美元
預計年份：2026年 65.6億美元
預測年份 2032 137.7億美元
複合年成長率 (%) 13.09%

恒溫核酸增幅技術正從專門的分子生物學工作流程轉向用於傳染病檢查、基因檢測、食品安全、環境監測、獸醫診斷和分散式分子檢測的前沿診斷平台。與PCR不同，恒溫環型核酸擴增（LAMP）、重組聚合酵素擴增（RPA）、基於核酸序列的擴增（NASBA）、解旋酶依賴性擴增（HDA）、鏈置換轉錄媒介增幅擴增（TMA）等等溫擴增儀方法可在恆溫條件下增強對DNA和RNA，從而依賴減少對複雜聚合酵素連鎖反應熱迴圈儀的方法。

這項技術的市場重要性源自於可衡量的醫療需求。世界衛生組織（世衛組織）仍將結核病、愛滋病、瘧疾和呼吸道感染疾病列為全球主要疾病負擔，後疫情時代的醫療衛生系統正在增加對快速分子診斷、即時檢測、抗菌素抗藥性監測和症候群監測的投資。恒溫核酸增幅透過提供更快的檢測結果、簡化設備、降低能耗以及在中心檢查室之外的潛在應用，為這些優先事項提供了支持。

等溫擴增領域的變革性變化

恒溫核酸增幅領域正因去中心化、檢測小型化以及與數位醫療系統的整合而重塑。檢查室和醫療機構正從批量處理的集中式分子檢測轉向以患者為中心的模式，從而支持在急診科、基層醫療機構、藥房、移動診所、邊境檢疫項目和現場環境中更快地做出臨床決策。

人工智慧（AI）的累積影響

人工智慧透過改進檢測設計、訊號解讀、品管和操作決策，正在為整個恒溫核酸增幅生態系統創造累積價值。人工智慧驅動的引子和探針設計可以降低脫靶擴增的風險，而機器學習模型則能夠更快地最佳化LAMP、RPA、NASBA、HDA、SDA、TMA及相關化學反應方法中的反應條件。

對關鍵區域的洞察

亞太地區是恒溫核酸增幅領域最具活力的地區之一，這主要得益於其龐大的人口基數、不斷加強的感染疾病監測、日益成長的國內診斷試劑生產能力以及公共衛生對快速檢測的需求。中國、印度、日本、韓國和澳洲正透過投資分子診斷、生物技術基礎設施、公共衛生實驗室和即時檢測（PoC）平台，推動這項技術的應用。同時，該地區的優先關注領域包括結核病、呼吸道感染疾病、登革熱、抗生素抗藥性、食品安全和動物健康監測。

主要群體分析

由於都市區人口稠密，熱帶疾病負擔沉重，跨國人口流動頻繁，以及各國政府對區域診斷自主化的重視，東協市場對恒溫核酸增幅技術的重要性日益凸顯。在東南亞，分子診斷工具已被廣泛應用於登革熱、結核病、呼吸道感染疾病、食品安全、水產養殖、牲畜疾病和動物健康監測等領域，因此，市場對價格合理、可現場應用且能在各種溫度和基礎設施環境下可靠運行的平台提出了更高的需求。

主要國家的概況

美國在商業性創新、FDA已通過核准的分子診斷、創業投資投資支持的檢測研發、公共衛生應急準備以及在醫院、急診室、藥房和分散式檢查環境中的部署方面處於主導。加拿大則專注於公共衛生監測、遠端通訊、原住民和北部社區的醫療保健需求以及品管診斷系統的部署。同時，墨西哥和巴西在感染疾病控制、農業檢測、獸醫學和加強社區檢查室方面對快速分子診斷工具的需求日益成長。

為行業領導者提供的實用建議

產業領導者應優先考慮檢測方法的穩健性、簡化的工作流程以及在所有檢體類型、環境條件和使用者技能水準下均能達到的臨床檢驗效能。最大的機會在於檢體系統、用於呼吸道和性行為感染感染 (STI) 的多參數檢測組合、抗生素抗藥性檢測、結核病檢測、被忽視的熱帶疾病檢測、食品安全、環境監測以及獸醫應用，在這些領域，速度和現場部署能夠創造可衡量的價值。

調查方法

本執行摘要採用結構化的二手研究途徑編寫，遵循嚴格的市場調查方法。分析整合了公開訊息，包括監管機構和公共衛生部門的資訊、同行評審文獻、臨床指南、產品文件、專利和技術趨勢綜述、採購趨勢以及與恒溫核酸增幅技術相關的科學論文。

結論

恒溫核酸增幅技術正成為快速分子診斷的重要支柱，因為它滿足了全球對便利、快速、可靠的核酸檢測的需求。該技術無需熱循環，因此非常適合分散式醫療、感染疾病集體爆發、資源匱乏環境、獸醫和食品安全工作流程以及高檢查室等應用場景，在這些場景中，簡化的設備能夠提高操作效率。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：恒溫核酸增幅技術市場：依產品類型分類

  • 裝置
    • 工作檯面
    • 可攜式的
  • 試劑和試劑盒
    • 控制材料
    • 酵素
    • 母帶混音
    • 引子和探針
  • 軟體服務
    • 服務
    • 軟體

第8章：恒溫核酸增幅技術市場：依工作流程分類

  • 放大
  • 檢測與分析
    • 端點檢測
    • 即時偵測
  • 預分析階段

第9章：恒溫核酸增幅技術市場：依技術分類

  • 解旋酶依賴性擴增
  • 恒溫環型核酸擴增
    • 比色檢測法
    • 螢光偵測
    • 濁度檢測法
  • 切口酵素增殖反應
  • 重組酶聚合酵素擴增法
    • 螢光偵測
    • 側向流動檢測方法
    • 即時偵測
  • 鏈置換擴增

第10章：恒溫核酸增幅技術市場：依最終用戶分類

  • 學術研究機構
  • 醫院/診斷檢查室
  • 製藥和生物技術公司
  • 照護端中心

第11章恒溫核酸增幅技術市場：依應用領域分類

  • 環境測試
  • 食品和飲料檢查
  • 基因檢測和篩檢
  • 感染疾病診斷
  • 獸醫診斷

第12章：恒溫核酸增幅技術市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：恒溫核酸增幅技術市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章恒溫核酸增幅技術市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Abbott Laboratories
  • AtilaBiosystems
  • Beijing SBS Genetech Co., Ltd.
  • bioMerieux SA
  • Biosearch Technologies by LGC Limited
  • DiaSorin SpA
  • Eiken Chemical Co., Ltd.
  • Fortis Life Sciences, LLC
  • GENOMTEC SA
  • GenoSensor Corporation
  • Grifols, SA
  • highQu GmbH
  • Hologic, Inc.
  • Illumina, Inc.
  • Jena Bioscience GmbH
  • Life Sciences Advanced Technologies, Inc.
  • Mast Group Ltd.
  • Meridian Bioscience Inc. by SD Biosensor, Inc.
  • New England Biolabs, Inc.
  • OptiGene Limited
  • PCR Biosystems Ltd.
  • QIAGEN GmbH
  • Quidel Corporation
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Ustar Biotechnologies（Hangzhou）Ltd
  • Xiamen Jiqing Biomedical Technology Co., Ltd.
  • Zhengzhou Laboao Instrument Equipment CO., LTD
  • Zhuhai Biori Biotechnology Co., Ltd.
Product Code: MRR-B9334AD6C2E2

The Isothermal Nucleic Acid Amplification Technology Market is projected to grow by USD 13.77 billion at a CAGR of 13.09% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.81 billion
Estimated Year [2026] USD 6.56 billion
Forecast Year [2032] USD 13.77 billion
CAGR (%) 13.09%

Isothermal nucleic acid amplification technology is moving from a specialized molecular biology workflow to a frontline diagnostic platform for infectious disease testing, genetic testing, food safety, environmental surveillance, veterinary diagnostics, and decentralized molecular testing. Unlike PCR, isothermal amplification methods such as loop-mediated isothermal amplification (LAMP), recombinase polymerase amplification (RPA), nucleic acid sequence-based amplification (NASBA), helicase-dependent amplification (HDA), strand displacement amplification (SDA), and transcription-mediated amplification (TMA) amplify DNA or RNA at a constant temperature, reducing dependence on complex thermal cyclers.

The technology's market relevance is supported by measurable healthcare needs: the World Health Organization continues to identify tuberculosis, HIV, malaria, and respiratory infections as major global disease burdens, while post-pandemic health systems have increased investment in rapid molecular diagnostics, point-of-care testing, antimicrobial resistance monitoring, and syndromic surveillance. Isothermal nucleic acid amplification supports these priorities by enabling faster turnaround, simpler instrumentation, lower energy requirements, and potential deployment outside centralized laboratories.

Transformative Shifts in the Isothermal Amplification Landscape

The isothermal nucleic acid amplification landscape is being reshaped by decentralization, assay miniaturization, and integration with digital health systems. Laboratories and healthcare providers are shifting from batch-based, centralized molecular testing toward near-patient models that support faster clinical decisions in emergency departments, primary care, pharmacies, mobile clinics, border health programs, and field environments.

Another major shift is the convergence of isothermal amplification with CRISPR-based detection, microfluidics, lyophilized reagents, lateral-flow readouts, and sample-to-answer cartridges. These advances are improving analytical sensitivity, reducing contamination risk, and supporting multiplex testing. Regulatory expectations are also becoming more rigorous, with stronger emphasis on clinical validation, usability studies, manufacturing controls, cybersecurity, and data integrity for diagnostics used beyond traditional laboratory settings.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating cumulative value across the isothermal nucleic acid amplification ecosystem by improving assay design, signal interpretation, quality control, and operational decision-making. AI-enabled primer and probe design can reduce off-target amplification risk, while machine learning models can support faster optimization of reaction conditions for LAMP, RPA, NASBA, HDA, SDA, TMA, and related chemistries.

In connected diagnostic platforms, AI can enhance image-based fluorescence, turbidity, electrochemical, or colorimetric readouts, identify invalid reactions, and support epidemiological analytics when results are aggregated through secure digital systems. The most immediate impact is not the replacement of laboratory expertise, but the augmentation of assay development and decentralized testing workflows with better automation, predictive analytics, real-time quality monitoring, and standardized result interpretation.

Key Regional Insights

Asia-Pacific is one of the most dynamic regions for isothermal nucleic acid amplification, driven by large population bases, rising infectious disease surveillance, expanding domestic diagnostics manufacturing, and public health demand for rapid testing. China, India, Japan, South Korea, and Australia are supporting adoption through investments in molecular diagnostics, biotechnology infrastructure, public health laboratories, and point-of-care platforms, while regional priorities include tuberculosis, respiratory infections, dengue, antimicrobial resistance, food safety, and animal health surveillance.

North America remains a high-value region due to strong clinical laboratory networks, regulated diagnostic innovation, reimbursement focus on actionable testing, and sustained demand for respiratory, sexually transmitted infection, healthcare-associated infection, and antimicrobial resistance testing. Europe shows broad adoption through hospital laboratories, public health networks, academic translational research, and in vitro diagnostic regulation under the IVDR, while Latin America is advancing uptake in tuberculosis, dengue, Zika, chikungunya, agricultural diagnostics, and veterinary testing where access to centralized PCR infrastructure can be uneven.

The Middle East is investing in healthcare modernization, molecular laboratory capacity, population screening programs, and infectious disease preparedness, particularly across Gulf health systems. Africa represents a critical opportunity for robust, low-infrastructure nucleic acid amplification, with demand shaped by tuberculosis, HIV, malaria, Ebola and other viral hemorrhagic fever preparedness, maternal and child health needs, and decentralized testing requirements in rural and resource-limited settings.

Key Group Insights

ASEAN markets are increasingly relevant for isothermal nucleic acid amplification because of dense urban centers, tropical disease burden, cross-border mobility, and government interest in regional diagnostic self-reliance. Countries across Southeast Asia are using molecular tools for dengue, tuberculosis, respiratory infections, food safety, aquaculture, livestock disease, and animal health surveillance, creating demand for affordable, field-ready platforms that can perform reliably in varied temperature and infrastructure conditions.

The GCC is advancing adoption through high per-capita healthcare spending, national laboratory modernization, medical tourism, genomic medicine programs, and infectious disease preparedness initiatives. The European Union provides a highly structured regulatory environment where compliance with IVDR, clinical performance evidence, quality management systems, and post-market surveillance are central to market access. BRICS countries are important for scale, localization, public-sector procurement, and cost-sensitive manufacturing, while G7 markets influence global standards through advanced R&D, reimbursement frameworks, quality assurance expectations, and early adoption of next-generation diagnostics.

NATO countries are also relevant because biosecurity, outbreak readiness, military medicine, force health protection, and field-deployable diagnostics are strategic priorities. Across these groups, procurement decisions increasingly favor isothermal amplification platforms that combine validated performance, supply resilience, digital connectivity, interoperability with surveillance systems, cold-chain reduction, and usability in decentralized environments.

Key Country Insights

The United States leads in commercial innovation, FDA-cleared molecular diagnostics, venture-backed assay development, public health preparedness, and adoption across hospital, urgent care, pharmacy, and decentralized testing settings. Canada emphasizes public health surveillance, remote access, Indigenous and northern community healthcare needs, and quality-controlled diagnostic deployment, while Mexico and Brazil show growing demand for rapid molecular tools in infectious disease control, agricultural testing, veterinary health, and regional laboratory strengthening.

In Europe, the United Kingdom, Germany, France, Italy, and Spain are advancing isothermal amplification through clinical diagnostics, academic research, hospital testing pathways, antimicrobial resistance initiatives, and regulated molecular testing adoption. Russia maintains demand for domestic molecular testing capacity and infectious disease monitoring, while Germany and France remain particularly important for technology validation, laboratory automation, quality systems, and regulated diagnostic adoption under European standards.

China is a major manufacturing and adoption hub, supported by scale, government-backed biotechnology growth, hospital infrastructure expansion, and broad infectious disease testing needs. India presents high potential due to tuberculosis, respiratory disease, antimicrobial resistance, maternal health needs, and decentralized healthcare requirements. Japan and South Korea contribute strong molecular diagnostics engineering, automation, microfluidics, and quality manufacturing capabilities, while Australia supports adoption through public health surveillance, veterinary diagnostics, biosecurity monitoring, and remote-area healthcare needs.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize assay robustness, simplified workflows, and clinically validated performance across sample types, environmental conditions, and user skill levels. The strongest opportunities are in sample-to-answer systems, multiplex respiratory and STI panels, antimicrobial resistance testing, tuberculosis detection, neglected tropical disease testing, food safety, environmental monitoring, and veterinary applications where speed and field deployment create measurable value.

Organizations should invest in lyophilized reagents, contamination control, closed-cartridge systems, internal controls, digital result capture, interoperability, and AI-assisted interpretation while building regulatory strategies early. Partnerships with public health agencies, regional manufacturers, reference laboratories, procurement bodies, and distribution networks can improve access and supply resilience. Commercial success will depend on proving not only analytical sensitivity and specificity, but also workflow efficiency, total cost of ownership, implementation feasibility, user training requirements, and clinical or public health impact.

Research Methodology

This executive summary is developed using a structured secondary research approach aligned with rigorous market intelligence practices. The analysis synthesizes publicly available information from regulatory agencies, public health authorities, peer-reviewed literature, clinical guideline sources, product documentation, patent and technology trend reviews, procurement signals, and scientific publications related to isothermal nucleic acid amplification technology.

Market interpretation is based on triangulation across disease burden, regulatory movement, technology readiness, laboratory infrastructure, public health priorities, reimbursement considerations, decentralized testing adoption, and observed trends in molecular diagnostics. Claims are framed conservatively and focus on verifiable trends, established technology capabilities, documented use cases, and observable demand drivers rather than speculative projections, market sizing, or market share estimates.

Conclusion

Isothermal nucleic acid amplification technology is becoming an essential pillar of rapid molecular diagnostics because it aligns with the global need for accessible, fast, and reliable nucleic acid testing. Its ability to operate without thermal cycling makes it well suited for decentralized healthcare, outbreak response, resource-limited environments, veterinary and food safety workflows, and high-throughput laboratory use cases where simplified instrumentation can improve operational efficiency.

The next phase of industry development will be defined by validated multiplexing, AI-supported assay development, CRISPR-enabled detection, connected point-of-care platforms, lyophilized reagent stability, and resilient manufacturing. Organizations that combine scientific rigor with usability, regulatory readiness, digital connectivity, and region-specific access strategies will be best positioned to lead adoption in clinical, public health, environmental, and industrial testing applications.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Isothermal Nucleic Acid Amplification Technology Market, by Product Type

  • 7.1. Instruments
    • 7.1.1. Benchtop
    • 7.1.2. Portable
  • 7.2. Reagents & Kits
    • 7.2.1. Control Materials
    • 7.2.2. Enzymes
    • 7.2.3. Master Mixes
    • 7.2.4. Primers & Probes
  • 7.3. Software & Services
    • 7.3.1. Services
    • 7.3.2. Software

8. Isothermal Nucleic Acid Amplification Technology Market, by Workflow

  • 8.1. Amplification
  • 8.2. Detection & Analysis
    • 8.2.1. End-Point Detection
    • 8.2.2. Real-Time Detection
  • 8.3. Preanalytical

9. Isothermal Nucleic Acid Amplification Technology Market, by Technology

  • 9.1. Helicase Dependent Amplification
  • 9.2. Loop Mediated Isothermal Amplification
    • 9.2.1. Colorimetric Detection
    • 9.2.2. Fluorescence Detection
    • 9.2.3. Turbidimetric Detection
  • 9.3. Nicking Enzyme Amplification Reaction
  • 9.4. Recombinase Polymerase Amplification
    • 9.4.1. Fluorescence Detection
    • 9.4.2. Lateral Flow Detection
    • 9.4.3. Real Time Detection
  • 9.5. Strand Displacement Amplification

10. Isothermal Nucleic Acid Amplification Technology Market, by End User

  • 10.1. Academic & Research Institutes
  • 10.2. Hospitals & Diagnostic Laboratories
  • 10.3. Pharmaceutical & Biotechnology Companies
  • 10.4. Point Of Care Centers

11. Isothermal Nucleic Acid Amplification Technology Market, by Application

  • 11.1. Environmental Testing
  • 11.2. Food & Beverage Testing
  • 11.3. Genetic Testing & Screening
  • 11.4. Infectious Disease Diagnostics
  • 11.5. Veterinary Diagnostics

12. Isothermal Nucleic Acid Amplification Technology Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Isothermal Nucleic Acid Amplification Technology Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Isothermal Nucleic Acid Amplification Technology Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Abbott Laboratories
  • 16.2. AtilaBiosystems
  • 16.3. Beijing SBS Genetech Co., Ltd.
  • 16.4. bioMerieux SA
  • 16.5. Biosearch Technologies by LGC Limited
  • 16.6. DiaSorin S.p.A.
  • 16.7. Eiken Chemical Co., Ltd.
  • 16.8. Fortis Life Sciences, LLC
  • 16.9. GENOMTEC S.A.
  • 16.10. GenoSensor Corporation
  • 16.11. Grifols, S.A.
  • 16.12. highQu GmbH
  • 16.13. Hologic, Inc.
  • 16.14. Illumina, Inc.
  • 16.15. Jena Bioscience GmbH
  • 16.16. Life Sciences Advanced Technologies, Inc.
  • 16.17. Mast Group Ltd.
  • 16.18. Meridian Bioscience Inc. by SD Biosensor, Inc.
  • 16.19. New England Biolabs, Inc.
  • 16.20. OptiGene Limited
  • 16.21. PCR Biosystems Ltd.
  • 16.22. QIAGEN GmbH
  • 16.23. Quidel Corporation
  • 16.24. Tecan Trading AG
  • 16.25. Thermo Fisher Scientific Inc.
  • 16.26. Ustar Biotechnologies (Hangzhou) Ltd
  • 16.27. Xiamen Jiqing Biomedical Technology Co., Ltd.
  • 16.28. Zhengzhou Laboao Instrument Equipment CO., LTD
  • 16.29. Zhuhai Biori Biotechnology Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BENCHTOP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BENCHTOP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BENCHTOP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PORTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PORTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PORTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL REAGENTS & KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL REAGENTS & KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CONTROL MATERIALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CONTROL MATERIALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CONTROL MATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENZYMES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENZYMES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENZYMES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MASTER MIXES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MASTER MIXES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MASTER MIXES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PRIMERS & PROBES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PRIMERS & PROBES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PRIMERS & PROBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL AMPLIFICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AMPLIFICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AMPLIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DETECTION & ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DETECTION & ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DETECTION & ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL END-POINT DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL END-POINT DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL END-POINT DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL REAL-TIME DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL REAL-TIME DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL REAL-TIME DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PREANALYTICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PREANALYTICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PREANALYTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HELICASE DEPENDENT AMPLIFICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HELICASE DEPENDENT AMPLIFICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HELICASE DEPENDENT AMPLIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL LOOP MEDIATED ISOTHERMAL AMPLIFICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL LOOP MEDIATED ISOTHERMAL AMPLIFICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL LOOP MEDIATED ISOTHERMAL AMPLIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL COLORIMETRIC DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL COLORIMETRIC DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL COLORIMETRIC DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL FLUORESCENCE DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL FLUORESCENCE DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL FLUORESCENCE DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL TURBIDIMETRIC DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL TURBIDIMETRIC DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL TURBIDIMETRIC DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NICKING ENZYME AMPLIFICATION REACTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NICKING ENZYME AMPLIFICATION REACTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NICKING ENZYME AMPLIFICATION REACTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL RECOMBINASE POLYMERASE AMPLIFICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL RECOMBINASE POLYMERASE AMPLIFICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL RECOMBINASE POLYMERASE AMPLIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL FLUORESCENCE DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL FLUORESCENCE DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL FLUORESCENCE DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL LATERAL FLOW DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL LATERAL FLOW DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL LATERAL FLOW DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL REAL TIME DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL REAL TIME DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL REAL TIME DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL STRAND DISPLACEMENT AMPLIFICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL STRAND DISPLACEMENT AMPLIFICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL STRAND DISPLACEMENT AMPLIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL HOSPITALS & DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL HOSPITALS & DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL HOSPITALS & DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL POINT OF CARE CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL POINT OF CARE CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL POINT OF CARE CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ENVIRONMENTAL TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ENVIRONMENTAL TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ENVIRONMENTAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL FOOD & BEVERAGE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL FOOD & BEVERAGE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL FOOD & BEVERAGE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL GENETIC TESTING & SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL GENETIC TESTING & SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL GENETIC TESTING & SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL VETERINARY DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL VETERINARY DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL VETERINARY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 201. GCC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 202. GCC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. GCC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 204. GCC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 205. GCC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 206. GCC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 207. GCC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 208. GCC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. GCC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 210. GCC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 211. GCC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. GCC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 237. G7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 238. G7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. G7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 240. G7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 241. G7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 242. G7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 243. G7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 244. G7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 245. G7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 246. G7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 247. G7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. G7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 249. NATO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 250. NATO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. NATO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 252. NATO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 253. NATO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 254. NATO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 255. NATO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 256. NATO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 257. NATO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 258. NATO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 259. NATO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. NATO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 274. CANADA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 275. CANADA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. CANADA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 277. CANADA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 278. CANADA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 279. CANADA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 280. CANADA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 281. CANADA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 282. CANADA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 283. CANADA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 284. CANADA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 285. CANADA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 286. MEXICO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 287. MEXICO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. MEXICO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 289. MEXICO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 290. MEXICO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 291. MEXICO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 292. MEXICO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 293. MEXICO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 294. MEXICO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMA